SCHEMBL1876273

SCHEMBL1876273

O=C(O)Cc1cccc(Nc2nccc(-c3c(-c4cccc(NC(=O)Cc5ccccc5)c4)nc4ccccn34)n2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 16/20 0.63
EGFR P00533 9/20 0.63
ERBB2 P04626 8/20 0.63
PTK2 Q05397 3/20 0.63
CDK19 Q9BWU1 2/20 0.63
KDR P35968 6/20 0.60
RET P07949 5/20 0.60
STK3 Q13188 5/20 0.60
MAP4K5 Q9Y4K4 5/20 0.60
CSF1R P07333 4/20 0.60
MAP4K2 Q12851 4/20 0.60
FLT1 P17948 3/20 0.60
PRKD3 O94806 4/20 0.59
MAP4K4 O95819 4/20 0.59
LCK P06239 4/20 0.59
FYN P06241 4/20 0.59
TAOK1 Q7L7X3 4/20 0.59
AURKB Q96GD4 4/20 0.59
INSR P06213 4/20 0.59
AURKA O14965 3/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1789889 0.94 IGF1R (0.64) IGF1REGFRERBB2PTK2CDK19
SCHEMBL1789532 0.94 IGF1R (0.62) IGF1REGFRERBB2PTK2CDK19
SCHEMBL1788382 0.92 IGF1R (0.66) IGF1REGFRERBB2PTK2CDK19
SCHEMBL1790035 0.91 IGF1R (0.70) IGF1REGFRERBB2PTK2CDK19
SCHEMBL1789122 0.90 IGF1R (0.79) IGF1REGFRERBB2PTK2CDK19
SCHEMBL1790678 0.90 IGF1R (0.80) IGF1REGFRERBB2PTK2CDK19
SCHEMBL1792604 0.89 IGF1R (0.59) IGF1REGFRERBB2PTK2CDK19
SCHEMBL1788249 0.89 IGF1R (0.61) IGF1REGFRERBB2PTK2CDK19
SCHEMBL1787813 0.88 IGF1R (0.66) IGF1REGFRERBB2PTK2CDK19
SCHEMBL1790603 0.88 IGF1R (0.68) IGF1REGFRERBB2PTK2CDK19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051315-B2 Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition ABBVIE INC. (US) 2015-06-09 US claimed
EP-2496574-A1 IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION Abbott Laboratories (US) 2012-09-12 EP claimed
US-9051315-B2 Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition ABBVIE INC. (US) 2015-06-09 US disclosed
EP-2496574-A1 IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION Abbott Laboratories (US) 2012-09-12 EP disclosed
WO-2011053476-A1 IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION ABBOTT LABORATORIES (US) 2011-05-05 WO disclosed